|
1) Bamett HL. The natural and treatment history of glomerular diseases in children-what can we learn from international cooperative studies？ In: A report of the International Study of Kidney Disease in Children. In Proceeding of the Sixth International Congress of Nephrology. Basel: Karger; 1976. p. 470-85
|
|
|
|
|
2) International Study of Kidney Disease in Children. Nephrotic syndrome in children. A randomized trial comparing two prednisolone regimens in steroid-responsive patients who relapse early. J Pediatr. 1979; 95: 239-42
|
|
|
|
|
3) Arbeitsgemeinschaft fur Padiatrische Nephrologie. Alternate day versus intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr. 1981; 135: 229-37
|
|
|
|
|
|
4) Arbeitsgemeinschaft fur Padiatrische Nephrologie. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet. l988: 1: 380-7
|
|
|
|
|
|
5) Brodehl J. The treatment of minimal change nephrotic syndrome: lessons learned from multicenter cooperative studies. Eur J Pediatr. 1991; 150: 380-7
|
|
|
|
|
|
6) Ehrich JHH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr. 1993; 152: 357-61
|
|
|
|
|
|
7) Ueda N, Chihara M, Kawaguchi S, et al. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr. 1988; 112: 122-6
|
|
|
|
|
|
8) 吉川徳茂, 伊藤 拓, 武越靖郎, 他. 小児ステロイド反応性ネフローゼ症候群, 柴苓湯併用症例における初期ステロイド治療の期間と再発—プロスペクティブコントロールスタディ—. 日腎会誌. 1998; 40: 587-90
|
|
|
|
|
9) Hodson EM, Knight JF, Willis NS, et al. Corticosteroid therapy for nephrotic syndrome in children. The Cochrane Database of Systematic Reviews The Cochrane Library, The Cochrane Collaboration Volume (4) 2004
|
|
|
|
|
|
10) Durkan A, Hodson EM, Willis NS, et al. Non-corticosteroid treatment for nephritic syndrome in children (Review). The Cochrane Library 2005, Issue 1. John Wiley & Sons. 2005
|
|
|
|
|
|
11) Cattran DC, Alexopoulos E, Heering P, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations. Kidney Int. 2007; 72: 1429-47
|
|
|
|
|
|
12) Kitano Y, Yoshikawa N, Tanaka R, et al. Ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1990; 4: 474-7
|
|
|
|
|
|
13) Tanaka R, Yoshikawa N, Kitano Y, et al. Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1993; 7: 249-52
|
|
|
|
|
|
14) Inoue Y, Iijima K, Nakamura H, et al. Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1999; 13: 33-8
|
|
|
|
|
|
15) Iijima K, Hamahira K, Kobayashi A, et al. Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome. J Am Soc Nephrol. 2000; 11: 2265-71
|
|
|
|
|
|
16) Hamahira K, Iijima K, Tanaka R, et al. Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol. 2001; 16: 723-37
|
|
|
|
|
|
17) Iijima K, Hamahira K, Tanaka R, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int. 2002; 61: 1801-5
|
|
|
|
|
|
18) Ishikura K, Ikeda M, Hattori S, et al. Effective and safe treatment with cyclosporine in nephritic children: a prospective, randomized multicenter trial. Kidney Int. 2008; 73: 1167-73
|
|
|
|
|
|
19) Barratt TM, Soothill JF. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970; 2: 479-82
|
|
|
|
|
|
20) Arbeitsgemeinschaft fur Padiatrische Nephrologie. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med. 1982; 306: 451-4
|
|
|
|
|
|
21) Arbeitsgemeinschaft fur Padiatrische Nephrologie. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Arch Dis Child. 1987; 62: 1102-6
|
|
|
|
|
|
22) Ueda N, Kuno K, Ito S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child. 1990; 65: 1147-50
|
|
|
|
|
|
23) Yoshioka K, Ohashi Y, Sakai T, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 2000; 58: 317-24
|
|
|
|
|
|
24) Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol. 1996; 7: 56-63
|
|
|
|
|
|
25) Ponticelli C, Rizzoni G, Edefonti A, et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993; 43: 1377-84
|
|
|
|
|
|
26) Ingulli E, Singh A, Baqi N, et al. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol. 1995; 5: 1820-5
|
|
|
|
|
|
27) Tune BM, Lieberman E, Mendoza SA. Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol. 1996; 10: 772-8
|
|
|
|
|
|
28) Waldo FB, Benfield MR, Kohaut EC. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr Nephrol. 1998; 12: 397-400
|
|
|
|
|
|
29) Mendoza SA, Reznik VM, Griswold WR, et al. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol. 1990; 14: 303-7
|
|
|
|
|
|
30) Yorgin PD, Krasher J, Al-Uzri AY. Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2001; 16: 245-50
|
|
|
|
|
|
31) Mori K, Honda M, Ikeda M. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2004; 19: 1232-6
|
|
|
|
|